Functional characterization of selected differentially methylated genes
Functionality of genes/gene names . | IGHV mutated . | IGHV unmutated . | IGHV3-21 . | Implicated role in cancer . | Accession number . | Reference . |
---|---|---|---|---|---|---|
IGHV mutated and IGHV unmutated CLL | ||||||
Tumor-suppressor genes | ||||||
ABI3* | Unmethylated | Methylated | Lost in cancer cell lines, implicated in lung metastasis | NM_016428.3 | 17 | |
SCGB2A1* | Unmethylated | Methylated | Methylated in lung cancer | NM_002407.1 | 18 | |
VHL | Unmethylated | Methylated | Mutated in sporadic cell renal carcinoma and von Hippel-Lindau syndrome | NT_022517.17 | 19 | |
PPP1R3A* | Methylated | Unmethylated | Deregulated in colorectal cancer | NM_002711.2 | 20 | |
WISP3 | Methylated | Unmethylated | Loss of expression in inflammatory breast cancer | NM_003880.2 | 21 | |
Genes enhancing proliferation | ||||||
ADORA3 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_020683.5 | 22 | |
AIRE | Methylated | Unmethylated | Regulated by the PKC pathway | NM_000383.1 | 23 | |
CARD15 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_022162.1 | 24 | |
FABP7 | Methylated | Unmethylated | Regulated by the MAPK/ERK pathway | NM_001446.3 | 25 | |
LOC340061 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_198282.1 | 26 | |
PRF1 | Methylated | Unmethylated | Enhancing the MAPK pathway | NM_005041.3 | 27 | |
UNC5CL | Methylated | Unmethylated | Activation of the NFκB pathway | NM_173561.1 | 28 | |
Genes facilitating tumorigenesis | ||||||
ANGPT2 | Methylated | Unmethylated | Preferentially expressed in unmutated CLL | NM_001147.1 | 29 | |
IFNB1 | Methylated | Unmethylated | Shown to enhance B-cell proliferation | NM_002176.2 | 30 | |
URP2 | Methylated | Unmethylated | Implicated in facilitating CLL tumorigenesis | NM_031471.4 | 31 | |
Antiapoptotic genes | ||||||
BCL2 | Methylated | Unmethylated | Known antiapoptotic gene, up-regulated in many cancers | NT_025028.13 | 32 | |
PLD1 | Unmethylated | Methylated | Stimulates cell-cycle progression by repressing p53 regulation of p21 | NM_002662.2 | 33 | |
Proapoptotic genes | ||||||
BCL10 | Unmethylated | Methylated | Proapoptotic genes, involved in p53 mediated cell death | NM_003921.2 | 34 | |
IL19 | Methylated | Unmethylated | Regulating apoptosis by activation of the STAT3 pathway | NM_013371.2 | 35 | |
Genes involved in prognosis | ||||||
NGFR | Unmethylated | Methylated | Highly expressed in favorable prognostic ALL patients | NM_002507.1 | 36 | |
IGHV unmutated and IGHV3-21 CLL | ||||||
Tumor-suppressor genes | ||||||
ABI3* | Methylated | Unmethylated | Lost in cancer cell lines, implicated in lung metastasis | NM_016428.3 | 17 | |
GPX3 | Methylated | Unmethylated | Deleted or methylated in prostate cancer | NM_002084.2 | 37 | |
IGSF4* | Methylated | Unmethylated | Down-regulated by methylation in neuroblastoma | NM_014333.2 | 38 | |
SERPIND5* | Methylated | Unmethylated | Tumor-suppressive properties in breast cancer | NM_002639.2 | 39 | |
SLC22A18 | Unmethylated | Methylated | Deregulated in several cancer forms | NM_183233.1 | 40 | |
Genes repressing proliferation | ||||||
LDOC1 | Unmethylated | Methylated | Implicated in repressing the NFκB pathway | NM_012317.2 | 41 | |
ZNF540 | Methylated | Unmethylated | Involved in down-regulating the MAPK pathway | NM_152606.2 | 42 | |
Genes facilitating tumorigenesis | ||||||
IL17RC | Unmethylated | Methylated | Shown to facilitate tumorigenesis in prostate cancer | NM_032732.2 | 43 | |
ANGPT2 | Unmethylated | Methylated | Expressed in IGHV unmutated CLL | NM_001147.1 | 29 | |
FHL2 | Methylated | Unmethylated | NM_201556.1 | |||
S100A14 | Unmethylated | Methylated | NM_020672.1 | |||
Antiapoptotic genes | ||||||
BCL2 | Unmethylated | Methylated | Known antiapoptotic gene, up-regulated in many cancers | NT_025028.13 | 32 | |
PLD1 | Methylated | Unmethylated | Stimulates cell-cycle progression by repressing p53 regulation of p21 | NM_002662.2 | 33 | |
IGHV mutated and IGHV3-21 CLL | ||||||
Genes enhancing proliferation | ||||||
LOC340061 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_198282.1 | 26 | |
PRF1 | Methylated | Unmethylated | Enhancing the MAPK pathway | NM_005041.3 | 27 | |
RASGRP3 | Methylated | Unmethylated | Regulated B-cell proliferation by facilitating B-cell receptor–RAS signaling | NM_170672.1 | 44 | |
Genes facilitating tumorigenesis | ||||||
LMO2 | Methylated | Unmethylated | Known proto-oncogene, expressed in human B-cell lymphomas | NM_005574.2 | 45 | |
URP2 | Methylated | Unmethylated | Implicated in facilitating CLL tumorgenesis | NM_031471.4 | 31 | |
NCRMS | Methylated | Unmethylated | XR_000219.2 | |||
Proapoptotic genes | ||||||
TP53I3 | Methylated | Unmethylated | Shown to induce p53-mediated cell death | NM_004881.2 | 46 | |
BCL10 | Unmethylated | Methylated | Proapoptotic genes, involved in p53-mediated cell death | NM_003921.2 | 34 | |
Genes involved in prognosis | ||||||
DNTT | Methylated | Unmethylated | Associated with poor prognosis in acute myeloid leukemia | NM_004088.3 | 47 |
Functionality of genes/gene names . | IGHV mutated . | IGHV unmutated . | IGHV3-21 . | Implicated role in cancer . | Accession number . | Reference . |
---|---|---|---|---|---|---|
IGHV mutated and IGHV unmutated CLL | ||||||
Tumor-suppressor genes | ||||||
ABI3* | Unmethylated | Methylated | Lost in cancer cell lines, implicated in lung metastasis | NM_016428.3 | 17 | |
SCGB2A1* | Unmethylated | Methylated | Methylated in lung cancer | NM_002407.1 | 18 | |
VHL | Unmethylated | Methylated | Mutated in sporadic cell renal carcinoma and von Hippel-Lindau syndrome | NT_022517.17 | 19 | |
PPP1R3A* | Methylated | Unmethylated | Deregulated in colorectal cancer | NM_002711.2 | 20 | |
WISP3 | Methylated | Unmethylated | Loss of expression in inflammatory breast cancer | NM_003880.2 | 21 | |
Genes enhancing proliferation | ||||||
ADORA3 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_020683.5 | 22 | |
AIRE | Methylated | Unmethylated | Regulated by the PKC pathway | NM_000383.1 | 23 | |
CARD15 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_022162.1 | 24 | |
FABP7 | Methylated | Unmethylated | Regulated by the MAPK/ERK pathway | NM_001446.3 | 25 | |
LOC340061 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_198282.1 | 26 | |
PRF1 | Methylated | Unmethylated | Enhancing the MAPK pathway | NM_005041.3 | 27 | |
UNC5CL | Methylated | Unmethylated | Activation of the NFκB pathway | NM_173561.1 | 28 | |
Genes facilitating tumorigenesis | ||||||
ANGPT2 | Methylated | Unmethylated | Preferentially expressed in unmutated CLL | NM_001147.1 | 29 | |
IFNB1 | Methylated | Unmethylated | Shown to enhance B-cell proliferation | NM_002176.2 | 30 | |
URP2 | Methylated | Unmethylated | Implicated in facilitating CLL tumorigenesis | NM_031471.4 | 31 | |
Antiapoptotic genes | ||||||
BCL2 | Methylated | Unmethylated | Known antiapoptotic gene, up-regulated in many cancers | NT_025028.13 | 32 | |
PLD1 | Unmethylated | Methylated | Stimulates cell-cycle progression by repressing p53 regulation of p21 | NM_002662.2 | 33 | |
Proapoptotic genes | ||||||
BCL10 | Unmethylated | Methylated | Proapoptotic genes, involved in p53 mediated cell death | NM_003921.2 | 34 | |
IL19 | Methylated | Unmethylated | Regulating apoptosis by activation of the STAT3 pathway | NM_013371.2 | 35 | |
Genes involved in prognosis | ||||||
NGFR | Unmethylated | Methylated | Highly expressed in favorable prognostic ALL patients | NM_002507.1 | 36 | |
IGHV unmutated and IGHV3-21 CLL | ||||||
Tumor-suppressor genes | ||||||
ABI3* | Methylated | Unmethylated | Lost in cancer cell lines, implicated in lung metastasis | NM_016428.3 | 17 | |
GPX3 | Methylated | Unmethylated | Deleted or methylated in prostate cancer | NM_002084.2 | 37 | |
IGSF4* | Methylated | Unmethylated | Down-regulated by methylation in neuroblastoma | NM_014333.2 | 38 | |
SERPIND5* | Methylated | Unmethylated | Tumor-suppressive properties in breast cancer | NM_002639.2 | 39 | |
SLC22A18 | Unmethylated | Methylated | Deregulated in several cancer forms | NM_183233.1 | 40 | |
Genes repressing proliferation | ||||||
LDOC1 | Unmethylated | Methylated | Implicated in repressing the NFκB pathway | NM_012317.2 | 41 | |
ZNF540 | Methylated | Unmethylated | Involved in down-regulating the MAPK pathway | NM_152606.2 | 42 | |
Genes facilitating tumorigenesis | ||||||
IL17RC | Unmethylated | Methylated | Shown to facilitate tumorigenesis in prostate cancer | NM_032732.2 | 43 | |
ANGPT2 | Unmethylated | Methylated | Expressed in IGHV unmutated CLL | NM_001147.1 | 29 | |
FHL2 | Methylated | Unmethylated | NM_201556.1 | |||
S100A14 | Unmethylated | Methylated | NM_020672.1 | |||
Antiapoptotic genes | ||||||
BCL2 | Unmethylated | Methylated | Known antiapoptotic gene, up-regulated in many cancers | NT_025028.13 | 32 | |
PLD1 | Methylated | Unmethylated | Stimulates cell-cycle progression by repressing p53 regulation of p21 | NM_002662.2 | 33 | |
IGHV mutated and IGHV3-21 CLL | ||||||
Genes enhancing proliferation | ||||||
LOC340061 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_198282.1 | 26 | |
PRF1 | Methylated | Unmethylated | Enhancing the MAPK pathway | NM_005041.3 | 27 | |
RASGRP3 | Methylated | Unmethylated | Regulated B-cell proliferation by facilitating B-cell receptor–RAS signaling | NM_170672.1 | 44 | |
Genes facilitating tumorigenesis | ||||||
LMO2 | Methylated | Unmethylated | Known proto-oncogene, expressed in human B-cell lymphomas | NM_005574.2 | 45 | |
URP2 | Methylated | Unmethylated | Implicated in facilitating CLL tumorgenesis | NM_031471.4 | 31 | |
NCRMS | Methylated | Unmethylated | XR_000219.2 | |||
Proapoptotic genes | ||||||
TP53I3 | Methylated | Unmethylated | Shown to induce p53-mediated cell death | NM_004881.2 | 46 | |
BCL10 | Unmethylated | Methylated | Proapoptotic genes, involved in p53-mediated cell death | NM_003921.2 | 34 | |
Genes involved in prognosis | ||||||
DNTT | Methylated | Unmethylated | Associated with poor prognosis in acute myeloid leukemia | NM_004088.3 | 47 |
These genes represent candidate tumor-suppressor genes.